{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:34:20Z","timestamp":1715646860536},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,13]]},"DOI":"10.7759\/cureus.60203","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T14:01:19Z","timestamp":1715608879000},"source":"Crossref","is-referenced-by-count":0,"title":["Utility of Serum Procalcitonin and Its Clearance in Predicting Outcomes in COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Nazia","family":"Mehfooz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajamul Hussain","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Mudasir","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar  H","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhail","family":"Mantoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajaz N","family":"Koul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushtaq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffar","family":"Bindroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaariq M","family":"Naqati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Clinical Spectrum of SARS-CoV-2 Infection. (2024). Accessed. May 2024: https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/clinical-spectrum\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107934","article-title":"Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab","volume":"385","author":"Gupta A","year":"2021","unstructured":"Gupta A, Gonzalez-Rojas Y, Juarez E, et al.. Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab. N Engl J Med. 2021, 385:1941-50. 10.1056\/NEJMoa2107934","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe Covid-19 in outpatients","volume":"386","author":"Gottlieb RL","year":"2022","unstructured":"Gottlieb RL, Vaca CE, Paredes R, et al.. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022, 386:305-15. 10.1056\/NEJMoa2116846","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-020-00432-3","article-title":"Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis","volume":"25","author":"Ghahramani S","year":"2020","unstructured":"Ghahramani S, Tabrizi R, Lankarani KB, et al.. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020, 25:30. 10.1186\/s40001-020-00432-3","journal-title":"Eur J Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis","volume":"26","author":"Malik P","year":"2021","unstructured":"Malik P, Patel U, Mehta D, et al.. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2021, 26:107-8. 10.1136\/bmjebm-2020-111536","journal-title":"BMJ Evid Based Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284520","article-title":"Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-a potential marker for disease severity","volume":"18","author":"Jeyapalina S","year":"2023","unstructured":"Jeyapalina S, Wei G, Stoddard GJ, et al.. Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-a potential marker for disease severity. PLoS One. 2023, 18:e0284520. 10.1371\/journal.pone.0284520","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106051","article-title":"Procalcitonin levels in COVID-19 patients","volume":"56","author":"Hu R","year":"2020","unstructured":"Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents. 2020, 56:106051. 10.1016\/j.ijantimicag.2020.106051","journal-title":"Int J Antimicrob Agents"},{"key":"ref8","article-title":"Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19","volume":"43","author":"Ahmed S","year":"2021","unstructured":"Ahmed S, Ahmed ZA, Rashid NH, Mansoor M, Siddiqui I, Jafri L. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19. Malays J Pathol. 2021, 43:375-80.","journal-title":"Malays J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00992-2","article-title":"COVID-19 and the role of cytokines in this disease","volume":"30","author":"Hasanvand A","year":"2022","unstructured":"Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology. 2022, 30:789-98. 10.1007\/s10787-022-00992-2","journal-title":"Inflammopharmacology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/00045632211022380","article-title":"Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection","volume":"58","author":"Heer RS","year":"2021","unstructured":"Heer RS, Mandal AK, Kho J, et al.. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection. Ann Clin Biochem. 2021, 58:520-7. 10.1177\/00045632211022380","journal-title":"Ann Clin Biochem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002321","article-title":"Serial procalcitonin predicts mortality in severe sepsis patients: results from the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study","volume":"45","author":"Schuetz P","year":"2017","unstructured":"Schuetz P, Birkhahn R, Sherwin R, et al.. Serial procalcitonin predicts mortality in severe sepsis patients: results from the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study. Crit Care Med. 2017, 45:781-9. 10.1097\/CCM.0000000000002321","journal-title":"Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/joacp.JOACP_388_19","article-title":"Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: a systematic review and meta-analysis","volume":"36","author":"Patnaik R","year":"2020","unstructured":"Patnaik R, Azim A, Mishra P. Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: a systematic review and meta-analysis. J Anaesthesiol Clin Pharmacol. 2020, 36:458-64. 10.4103\/joacp.JOACP_388_19","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"ref13","article-title":"The clinical utility of serial procalcitonin and procalcitonin clearance in predicting the \u200eoutcome of COVID-19 Egyptian patients","volume":"1","author":"Taha SI","year":"2022","unstructured":"Taha SI, Shata AK, Baioumy SA, et al.. The clinical utility of serial procalcitonin and procalcitonin clearance in predicting the \u200eoutcome of COVID-19 Egyptian patients. Egyptian Patients.Afro-Egyptian Journal of Infectious and Endemic Diseases. 2022, 1:115-23.","journal-title":"Egyptian Patients.Afro-Egyptian Journal of Infectious and Endemic Diseases"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.03.004","article-title":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"505","author":"Lippi G","year":"2020","unstructured":"Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta. 2020, 505:190-1. 10.1016\/j.cca.2020.03.004","journal-title":"Clin Chim Acta"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07144-5","article-title":"High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department","volume":"22","author":"Tong-Minh K","year":"2022","unstructured":"Tong-Minh K, van der Does Y, Engelen S, et al.. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department. BMC Infect Dis. 2022, 22:165. 10.1186\/s12879-022-07144-5","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57101070","article-title":"Procalcitonin levels in COVID-19 patients are strongly associated with mortality and ICU acceptance in an underserved, inner city population","volume":"57","author":"Feng T","year":"2021","unstructured":"Feng T, James A, Doumlele K, et al.. Procalcitonin levels in COVID-19 patients are strongly associated with mortality and ICU acceptance in an underserved, inner city population. Medicina (Kaunas). 2021, 57:10.3390\/medicina57101070","journal-title":"Medicina (Kaunas)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272840","article-title":"Procalcitonin as a predictive marker in COVID-19: a systematic review and meta-analysis","volume":"17","author":"Kumar A","year":"2022","unstructured":"Kumar A, Karn E, Trivedi K, et al.. Procalcitonin as a predictive marker in COVID-19: a systematic review and meta-analysis. PLoS One. 2022, 17:e0272840. 10.1371\/journal.pone.0272840","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.972659","article-title":"Evaluation of procalcitonin elevation during ICU stay and its relationship with mortality in ICU patients for COVID-19 with respiratory involvement. A multicenter prospective cohort study","volume":"9","author":"Rivera-Fernandez R","year":"2022","unstructured":"Rivera-Fernandez R, Y\u00e1guez-Mateos L, Guerrero-Marin M, et al.. Evaluation of procalcitonin elevation during ICU stay and its relationship with mortality in ICU patients for COVID-19 with respiratory involvement. A multicenter prospective cohort study. Front Med (Lausanne). 2022, 9:972659. 10.3389\/fmed.2022.972659","journal-title":"Front Med (Lausanne)"},{"key":"ref19","article-title":"Usefulness of procalcitonin clearance to predict mortality in abdominal sepsis","volume":"18","author":"Peng JC","year":"2020","unstructured":"Peng JC, Xu QY, Ding J, et al.. Usefulness of procalcitonin clearance to predict mortality in abdominal sepsis. Eur J Inflamm. 2020, 18:","journal-title":"Eur J Inflamm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0885066619861588","article-title":"Procalcitonin clearance at 24, 48, 72, and 96 hours and mortality in patients with cancer and sepsis: a retrospective cohort study","volume":"35","author":"Nassar AP Jr","year":"2020","unstructured":"Nassar AP Jr, Nassif BN, Santos DV, Caruso P. Procalcitonin clearance at 24, 48, 72, and 96 hours and mortality in patients with cancer and sepsis: a retrospective cohort study. J Intensive Care Med. 2020, 35:1297-301. 10.1177\/0885066619861588","journal-title":"J Intensive Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110626","article-title":"Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones","volume":"122","author":"Haroun RA","year":"2023","unstructured":"Haroun RA, Osman WH, Amin RE, Eessa AM, Saad S. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones. Int Immunopharmacol. 2023, 122:110626. 10.1016\/j.intimp.2023.110626","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.951556","article-title":"Comparative analysis of neutrophil to lymphocyte ratio and derived neutrophil to lymphocyte ratio with respect to outcomes of in-hospital coronavirus disease 2019 patients: a retrospective study","volume":"9","author":"Asghar MS","year":"2022","unstructured":"Asghar MS, Akram M, Yasmin F, et al.. Comparative analysis of neutrophil to lymphocyte ratio and derived neutrophil to lymphocyte ratio with respect to outcomes of in-hospital coronavirus disease 2019 patients: a retrospective study. Front Med (Lausanne). 2022, 9:951556. 10.3389\/fmed.2022.951556","journal-title":"Front Med (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253418-utility-of-serum-procalcitonin-and-its-clearance-in-predicting-outcomes-in-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T14:01:25Z","timestamp":1715608885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253418-utility-of-serum-procalcitonin-and-its-clearance-in-predicting-outcomes-in-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.60203","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,13]]}}}